Interact to see
Advertisement
Advertisement
HRCCX vs RGEBX
HRCCX vs RGEBX Comparison
Open Charts HRCCX vs RGEBX
Carillon ClariVest Capital Apprec C
Price$28.27
Change-$0.39 (-1.36%)
VolumeN/A
Net Assets503M
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
HRCCX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HRCCX vs. RGEBX commentary
Jun 15, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRCCX is a Buy and RGEBX is a Buy.
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. HRCCX (503M). HRCCX (0.00) and RGEBX (0.00) have matching dividends . HRCCX was incepted earlier than RGEBX: HRCCX (30 years) vs RGEBX (11 years). HRCCX (1.75) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. HRCCX (22.00). RGEBX has a lower initial minimum investment than HRCCX: RGEBX (250) vs HRCCX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. HRCCX (1.95). RGEBX return over 5 years is better than : 45.42 vs. HRCCX (-11.88).
| HRCCX | RGEBX | HRCCX / RGEBX | |
| Total Expense Ratio | 1.75 | 1.09 | 161% |
| Annual Report Gross Expense Ratio | 1.75 | 1.09 | 161% |
| Fund Existence | 30 years | 11 years | - |
| Gain YTD | 1.727 | 4.829 | 36% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 503M | 306B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 1.95 | 7.68 | 25% |
| Returns for 3 years | 4.01 | 51.01 | 8% |
| Returns for 5 years | -11.88 | 45.42 | -26% |
| Returns for 10 years | -10.57 | 65.87 | -16% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CVSIX | 15.56 | -0.02 | -0.13% |
| Calamos Market Neutral Income A | |||
| DBORX | 23.82 | -0.21 | -0.87% |
| BNY Mellon Balanced Opportunity I | |||
| OGIIX | 50.52 | -0.50 | -0.98% |
| Invesco Global Opportunities R6 | |||
| ERHSX | 14.18 | -0.15 | -1.05% |
| Eaton Vance Worldwide Health Sci R | |||
| BOGSX | 7.57 | -0.13 | -1.69% |
| Black Oak Emerging Technology | |||